Daratumumab Biosimilar - Research Grade

6.75mg/ml

Human IgG1 Kappa

Humanized

Detects human CD38. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Daratumumab.

CD38 is a multifunctional ectoenzyme and surface marker highly expressed on plasma cells, making it an important target in haematology and immunology research. This research-grade anti-human CD38 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of daratumumab, built around the CD38 target as a human IgG1-kappa for research use only. Produced to in vivo standards as an ultra-pure, low-endotoxin preparation, it is supplied in scalable milligram to gram quantities for high-throughput and bulk laboratories. It functions as a control and active reagent across preclinical work, including binding and depletion assays, in vitro screening, in vivo models, and ADCC studies.

P56528